2013-04-10

[DIV28SUPER] Division 28 program for APA 2013 meeting in Hawaii

Dear members,

Please find the Division 28 program for APA 2013 meeting in Hawaii attached. 

Thanks to the hard work and dedication of the Division 28 members and executive committee we have put together an exceptional program filled with research in behavioral economics, technology, drug use vulnerability, and mental health.  I hope everyone enjoys and I look forward to seeing everyone at the conference! 

 

 

Kathryn Saulsgiver, Ph.D.

Division 28 APA Program Chair

Center for Health Incentives and Behavioral Economics

University of Pennsylvania

730 Blockley Hall

423 Guardian Drive

Philadelphia, PA 19104-6021

email: kasau@mail.med.upenn.edu

phone: 215.746.4923

fax: 215-573-4132

 

 

2013-04-09

[DIV28SUPER] Cellular Biology of Addiction Course August 6- August 12, 2013: Applications due April 15, 2013

 

 

 

 

How To Apply

Selection Process and Stipends

Travel

General Information

Campus Information

CELLULAR BIOLOGY OF ADDICTION
August 6 - 12, 2013
Application Deadline: April 15, 2013

Instructors:
Antonello Bonci, NIDA
Christopher Evans, University of California, Los Angeles
Brigitte Kieffer, IGBMC, France
Rafael Maldonado, Universitat Pompeu Fabra, Spain
Mark Von Zastrow, University of California, San Francisco

Drug addiction is the most costly neuropsychiatric disorder faced by our nation. Acute and repeated exposure to drugs produces neuroadaption and long-term memory of the experience, but the cellular and molecular processes involved are only partially understood. The primary objective of the proposed workshop is to provide an intense dialogue of the fundamentals, state-of-the-art advances and major gaps in the cell and molecular biology of drug addiction.Targeted to new or experienced investigators, the workshop will combine formal presentations and informal discussions to convey the merits and excitement of cellular and molecular approaches to drug addiction research. With the advent of genomics and proteomics, an extraordinary opportunity now exists to develop comprehensive models of neuroadaptative processes fundamental to addiction, withdrawal, craving, and relapse to drug use and to brain function, in general. A range of disciplines and topics will be represented, including noninvasive brain imaging to identify drug targets and adaptive processes; neuroadaptative processes at the molecular and cellular level, neural networks and their modulation, the relevance of genotype to susceptibility and drug response; tolerance and adaptation at the cellular level and approaches to exploiting the daunting volume generated by neuroinformatics. This workshop will provide an integrated view of current and novel research on neuroadaptive responses to addiction, foster discussion on collaboration and integration, provide critical information needed to construct a model of addiction as a disease and novel molecular targets for biological treatments. Beyond the plane of scientific endeavor, the information is vital for formulating public policy and for enlightening the public on the neurobiological consequences of drug use and addiction. The workshop is designed to generate interest in this level of analysis, open conduits for collaborations and present novel routes to investigating the neurobiology of addictive drugs.

Confirmed Speakers include:
Charles Chavkin, David Goldman, Markus Heilig,
Paul J. Kenny, George Koob, Barbara Mason, Angus Nairn,
Eric Nestler, Marina Picciotto, R. Christopher Pierce,
Rajita Sinha, Scott Sternson, Nora Volkow and William Yang

The course will be held at the Laboratory's Banbury Conference Center located on the north shore of Long Island. All participants stay within walking distance of the Center, close to tennis court, pool and private beach.

This course is supported with funds provided by the National Institute of Drug Abuse. Scholarship funds are available for partial support of tuition, room and board on a merit basis.

Cost (including board and lodging): $2,515
Currency converter

Supported by NIDA grant R13DA019791

 

 

 

Cold Spring Harbor Laboratory
Meetings & Courses Program

 

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov<mailto:listserv@list.nih.gov>, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov     301-435-1309

2013-04-03

[DIV28SUPER] Fwd: faculty job openings

On behalf of Joy Schmitz, please see attached for open faculty positions with the CNRA research group at the University if Texas - Houston.

[DIV28SUPER] 2013 Young Scientist Research Fund Awards,

ADHD Research Award Program 2013 – Applications Now Available

 

CHADD (Children and Adults with Attention-Deficit/Hyperactivity Disorder) is pleased to announce the 2013 Young Scientist Research Fund Awards, a program to recognize young researchers making contributions to the understanding of ADHD. 

 

Two awards will include an unrestricted cash prize of $5,000, recognition at CHADD's 25th Annual International Conference in Crystal City, VA (Washington, DC Area), conference travel, registration and expense allowance and a one-year professional membership to CHADD.  Applicants must be in the process of completing a doctoral degree or have completed one within the last three years with the doctoral degree awarded no earlier than January 2010.

 

Research may address any area relevant to ADHD including, but not limited to: biological/genetic underpinnings of the disorder; treatment efficacy; impact on the individual or family; school or workplace accommodations; social stigma and discrimination; public health; and epidemiology.

 

The awards are currently being supported through a generous grant from Janssen Pharmaceuticals, Inc. of Titusville, NJ and by a number of individual donations.

 

Deadline for applications is May 15, 2013.  For an application or for more information, go to www.chadd.org/youngscientist  or send an email to youngscientist@chadd.org .

 

Thank you very much for your time and consideration.

 

Sincerely,

 

Ms. Zuali Malsawma

Librarian

National Resource Center on AD/HD: A Program of CHADD

8181 Professional Place - Suite 150
Landover, MD 20785
Tel:  240-487-2330

Fax: 301-306-6788

Zuali_Malsawma@chadd.org

www.help4adhd.org / www.chadd.org

 

 

2013-04-02

[DIV28M] new bylaws

Dear APA Division 28 Members-
Voting closed yesterday on the proposed bylaws changes. The changes were approved by more than 2/3 of those voting (the threshold to change bylaws), so the changes are now in effect. I have attached a copy of these updated bylaws for your records.
Please let me know if you have any questions.
Thanks,
Bill Stoops.
Division 28 Secretary.

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
Assistant Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are
confidential and are intended solely for the addressee. The information
may also be legally privileged. This transmission is sent in trust, for
the sole purpose of delivery to the intended recipient. If you have
received this transmission in error, any use, reproduction or
dissemination of this transmission is strictly prohibited. If you are
not the intended recipient, please immediately notify the sender by
reply e-mail or at (859) 257-5383 and delete this message and its
attachments, if any.

[DIV28SUPER] FDA response to citizen petitions on Nicotine containing products

http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/ucm345928.htm?source=govdelivery


"....  

Nicotine-Containing Products

FDA has issued a citizen petition response and a Notice of Findings related to over-the-counter (OTC) nicotine replacement therapy (NRT) products, which are currently approved as aids to smoking cessation. 

 
Citizen Petition Response
In January 2008, The State of New York's Commissioner of Health submitted a citizen petition to the Agency asking FDA to take various actions regarding the regulation of OTC NRT drug products. In February 2010, the University of Maryland School of Law submitted a petition raising similar issues on behalf of the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco. We received a third petition in August 2010, from four not-for-profit public health organizations: the American Cancer Society Cancer Action Network, the American Lung Association, the Campaign for Tobacco-Free Kids, and the American Legacy Foundation. These three petitions raise many common issues, so FDA issued a combined response granting and denying the various requests made in the petitions. 
    
Notice of Findings
Each of the citizen petitions described above requested changes to approved drug product labeling for OTC NRT products. Because changes to the labeling of OTC NRT products must be supported by submissions from product sponsors to the appropriate New Drug Applications, FDA was unable to make the requested labeling changes through the citizen petition process. The Agency has, however, conducted its own review of the available literature and data on the safety of OTC NRT products. Based on that review, we have concluded that certain statements set forth in the approved labeling of OTC NRT products, including statements related to duration of use and concomitant use with other nicotine-containing products, can be modified. FDA intends to allow the modification of these statements based on sponsor submissions as set forth in a Notice of Findings.
 
Product sponsors may contact CDER's Division of Nonprescription Clinical Evaluation for samples of what the new labeling would look like with the changes supported by the Notice of Findings.
 
Contact:
Doris J. Bates, Ph.D.
Center for Drug Evaluation and Research
Food and Drug Administration  ...."

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

2013-04-01

[DIV28SUPER] Not an April Fool's Joke!

 

No… this is NOT an April Fool’s joke! There is STILL time to register and attend the Inaugural Collaborative Perspectives on Addiction Conference!

 

Your registration includes:

 

1)    Two amazing keynotes by Saul Shiffman and Edith Sullivan

2)    Up to 13.5 hours of CE!

3)    Two amazing poster sessions chalked full of research

4)    Free lunch and presentation by Harold Perl of NIH: “Peeking Behind the Curtain of the NIH Funding Process: Tips for Preparing a Successful Grant Application”

5)    10 symposia to choose from (see below for list)

6)    Networking and camaraderie over two social hours!

7)    A chance to visit the heart of the South and all that Atlanta has to offer!

 

Register today at www.tinyurl.com/2013CPA

 

 

-------

 

 

The following sessions will be presented at the upcoming 2013 Collaborative Perspectives on Addiction Conference.

 

>BEHAVIORAL ECONOMIC PERSPECTIVES ON ADDICTION
The field of behavioral economics, or the study of economic decision-making with behavioral experimentation, has contributed a great deal to the understanding of addiction and the altered decision-making patterns often seen in addiction. In this session, four behavioral economic researchers (Warren Bickel, James MacKillop, James Murphy, and Mikhail Koffarnus) will present recent research in this area and discuss the unique contributions of behavioral economics to the understanding of addiction.
Warren Bickel, PhD; Mikhail Koffarnus, PhD; James MacKillop, PhD; James Murphy, PhD

 

>APPLYING CLINICAL NEUROSCIENCE TO THE TREATMENT OF ADDICTION
Addiction is a chronic and relapsing disorder affecting millions of patients worldwide. Extensive preclinical research has elucidated some of the key neurobiological underpinnings of addiction, yet these findings have not been translated into clinical practice. This workshop will review addiction neurobiology while applying theses insights to the understanding of the clinical phenomenology and treatment of the disorder. Participants will learn how to integrate key findings from addiction neuroscience into the psychological treatment of addiction.
Kelly Courtney, PhD; Lara Ray, PhD

 

>BIOBEHAVIORAL PERSPECTIVES ON MECHANISMS OF BEHAVIOR CHANGE: BRAIN, BODY, MIND, AND CONTEXT
This session will introduce some “out of the box” biobehavioral perspectives on research and practice approaches to identifying and manipulating mechanisms of behavior change in addictions. The construct of arousal will be probed at the level of the brain, the body, the mind, and in social interaction. Implications for developing a multi-level explanatory framework to understand behavior change will be discussed. Video clips and audience-involved demonstrations will be included.
Marsha Bates, PhD; David Eddie, MS;  Jon Morgenstern, PhD; Robert Zucker, PhD, ABPP

 

>CO-MORBID INHALANT USE AND COMPULSORY BEHAVIORS: IMPLICATIONS FOR RED-FLAG ASSESSMENTS AND STRATEGIES FOR CLINICAL CARE
The present study explored the relationship between compulsory behaviors, trauma history, and increased prevalence of inhalant abuse in females versus males in adolescent substance users.  A major focus of this study was to provide practical guidelines for clinicians treating adolescents with substance use disorders by way of assessment and treatment planning strategies.  The findings are tied directly into strategies for treatment planning in a tangible attempt to bridge the divide between research and clinical practice.
Robert Daniels, MA; Tommi Rivers, BA

 

>INTERDISCIPLINARY TREATMENT TEAMS FOR ADDICTIVE DISORDERS ON COLLEGE CAMPUSES
This symposium describes the methods and benefits of integrated, interdisciplinary treatment team approaches for eating disorders and alcohol and other drug (AOD) abuse on a college campus.
Irene Dalton, PhD; Abby Myers, PhD; Shannon Croft, MD; Kelita Wiley, MD

 

>MEDIATORS OF THE ASSOCIATION OF DEPRESSION WITH SMOKING CESSATION
This study examined the mechanisms linking depression to smoking cessation in an ethnically diverse sample (N=424).  Greater depression was associated with significantly lower cessation rates. Positive affect, stress, self-efficacy, expectancies of controlling negative affect by means other than smoking, affective withdrawal symptoms, and social support individually mediated the effect of depression on smoking cessation. However, when taking into account other significant mediators, only self-efficacy and sadness uniquely mediated the effect of depression on smoking cessation.
Virmarie Correa Fernandez, PhD; Whitney L. Heppner, PhD; Diana Stewart, PhD; Amanda Mathew, MA

 

>MEDICATION DEVELOPMENT: TRANSLATING RESEARCH INTO PRACTICE
This breakout session examines the development and implementation of medication for the treatment of alcohol and drug use disorders.  Presentation 1 discusses development of an immunotherapy for methamphetamine use.  Presentation 2 reports on the system changes required to promote the use of medication.  Presentation 3 examines the use of medication within addiction treatment centers.  Presentation 4 is a case study of medication use in a community-based treatment center participating in the Clinical Trials Network.
John Gardin; Jennifer Loftis; Dennis McCarth; Traci Rieckmann

 

>NEUROECONOMICS AS A FRAMEWORK FOR TRANSLATIONAL RESEARCH ON ADDICTION
Neuroeconomics is an interdisciplinary research approach that has characterized neural abnormalities underlying pathological decision making in individuals who misuse a variety of substances. The four talks in this session will highlight recent neuroeconomics research in addiction with a particular focus on neuroimaging studies of impulsive delay discounting and substance demand along with pharmacological and genetic influences on these variables. An interactive panel discussion will focus on translational implications for interventions for addictive disorders.
Michael Amlung, MS; Charlotte Boettiger, PhD; James MacKillop, PhD; Joseph Schacht, PhD

 

>THE APPLICATION OF CLINICAL NEUROSCIENCE IN TREATING ADDICTIVE DISORDERS
This symposium highlights the application of clinical neuroscience in understanding and treating addictive disorders. Review of recent studies and the role of psychopharmacology and integrative treatment will be discussed.
Meghan Marcum, PsyD

 

>UNDERSTANDING AND TREATING THE CO-OCCURRING DISORDERED CLIENT
This session will explore the underlying characteristics of individuals with confounding mental health and substance use disorder issues and will explore specific treatment strategies for this population.
Vito DonGiovanni, PhD

 

 

 

 

·         Conference Website, Registration, and Hotel: www.tinyurl.com/2013CPA

·         See who’s registered so far! https://divisions.wufoo.com/reports/2013-cpa-attendee-directory/

·         See all the details on the attached Brochure

 

 

ABOUT THE CONFERENCE

The theme for the 2013 conference is "Biobehavioral RESEARCH & Implications for PRACTICE"

·         Atlanta, Georgia / May 3-4, 2013

·         Two thought-provoking keynote sessions

·         Interactive environment for collaboration/networking

·         Several breakout session choices

·         Poster Sessions

·         Pre-conference in-depth workshops

·         Discounted rates for Early Career Psychologists

·         Student opportunities (discounted rates, special networking, etc)

·         You don't have to be a member of either or division or APA to attend the conference!

·         13.5 hours of CE are available AND included in the price

 

 

MEET THE KEYNOTERS

·         Saul Shiffman, PhD, is a world-renowned researcher in the fields of behavior change and relapse, self-management and self-control, field research methodology, statistical analysis, and addiction and dependence. Since 1991, he has been a professor in the departments of psychology and pharmaceutical science at the University of Pittsburgh. Dr. Shiffman has taught in the departments of psychology and psychiatry and behavioral medicine at various universities, including the University of South Florida, the University of Washington, and the University of Pittsburgh. Dr. Shiffman has authored or co-authored over 300 published papers on a variety of topics related to psychopharmacology, substance abuse, dependence, relapse, coping, and computerized assessments of behavior, and has presented widely in medical and scientific forums. A fellow of numerous professional societies (including APA Divisions 28 and 50), Dr. Shiffman was awarded the Society for Research on Nicotine and Tobacco’s Ovid Ferno Award for “ground breaking advances in clinical research.”

·         Edith V. Sullivan, PhD, is professor of psychiatry and behavioral sciences at Stanford University School of Medicine and a neuropsychologist who has pioneered the study of alcoholism-related brain injury on selective cognitive and motor function. She is the recipient of a Senior Scientist Research and Mentorship Award, a grant for international collaborations on alcoholism research, and an NIAAA MERIT award for studies of neural circuitry modification in alcoholism focused on frontocerebellar systems. Dr. Sullivan is a recipient of the Research Society on Alcoholism Distinguished Researcher Award and is author of more than 250 peer-reviewed papers and numerous chapters and reviews. Dr. Sullivan will present a keynote address on Saturday, May 4, titled “Alcoholism and the Brain: Road to Ruin and Path to Recovery.”

 

PRE-CONFERENCE WORKSHOP

"Conducting Neuroimaging Studies from a Neuropsychologist’s Perspective"

Integrating neuroimaging techniques with neuropsychological and other neurobehavioral methods is often a powerful approach in human studies. Many applicants underappreciate the critical processes that enable a) identification of appropriate team members, b) building cohesion among members, and c) sustaining individual commitment and engagement throughout the project. Furthermore, psychologists without neuroimaging expertise often fail to fully utilize the expertise of their collaborators and thus struggle to communicate the import of their data. Building on existing literature and her own experiences, Dr. Mattson’s workshop focuses on essential steps in defining effective, productive and innovative teams from the perspective of “non-imagers.”

Presenter: Sarah Mattson, PhD (Pre-Registration Required)

 

LUNCHEON PRESENTATION

“Peeking Behind the Curtain of the NIH Funding Process: Tips for Preparing a Successful Grant Application”

Applying for NIH research funding can be a daunting prospect, especially in a tough budget environment, yet thousands of submissions are funded in every cycle. Successful applications are not just based on important and innovative ideas but how those ideas are formulated and presented.  Dr. Harold Perl is a 23-year veteran of NIDA and NIAAA. He presents an in-depth analysis of the application process that will help investigators at all levels enhance their grantsmanship and increase their chances of success. Attendees also will get an illuminating behind-the-scenes look at the review and funding process from this key NIH “insider.”

Presenter: Harold Perl, PhD, the Chief of the Prevention Research Branch at NIDA. Presentation includes complimentary luncheon; all attendees welcome.

 

ABOUT THE VENUE

The beautiful W Hotel in Midtown Atlanta will be the venue for our First Annual Conference. The hotel is located in the heart of Midtown and is local to public transportation. Room rates are $159 per night. Reserve your room now!

 

MORE INFORMATION

Sara Jo Nixon, PhD, Conference Chair

Anthony Liguori, PhD, Conference Co-Chair

John Kelly, PhD, Sponsorship Co-Chair

Katie Witkiewitz, PhD, Sponsorship Co-Chair

Jennifer Buckman, PhD, Conference Treasurer

Chad Rummel, MEd, Registration and Hotel Accommodations (202-336-6121)

 

Conference Website and Registration: www.tinyurl.com/2013CPA

 

 

 

______________________________________________

Chad Rummel, MEd | Registration and Meeting Planner

2013 Collaborative Perspectives on Addiction Conference

Register Today   |   Reserve Your Hotel Room    |   See All Atlanta Has to Offer!

 

 

Division Services Office | Governance Affairs

CODAPAR Staff Liaison

American Psychological Association

750 First Street NE, Washington, DC 20002-4242

Tel: (202) 336-6121 | Fax: (202) 218-3599 |  crummel@apa.org

Join divisions online at www.apa.org/divapp